Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Ezz-Eldin YM, Aboseif AA, Khalaf MM
Analyst View The GLP-1 receptor agonist market represents one of the most dynamic therapeutic segments in modern healthcare, driven by the escalating global diabetes epidemic and rising obesity prevalence
Individual receptor sensitivity, baseline insulin resistance, genetic polymorphisms in GLP-1 and GIP receptors, and prior treatment duration all affect response
The Academy of Nutrition and Dietetics, along with most guidelines, recommends staying well above 1,5001,800 calories a day
Its triple-action influence on metabolic pathways ensures sustainable and effective fat loss
Interestingly, this study was conducted on participants with metabolic syndrome, so the results are promising for many patients today dealing with similar issues
US$ 28.60
US$ 22.42
US$ 28.11
US$ 21.90
